HERE WITH PROACTIVE PRESCRIPTION TIPS.

From the conversation with your doctor through receiving your COPAXONE® from the pharmacy, we’ll show you how to be proactive about your prescription—and why it’s important.


Are there generics available for COPAXONE®?

Yes. However, if you’re looking for affordable access to your RMS therapy, know that most people taking COPAXONE® 40 mg—more than 70%—pay less than $10 per month out of pocket. Medication costs vary for everyone based on insurance coverage, but to date, over 80% of healthcare plans cover Teva's COPAXONE®.1 Learn how Teva's Shared Solutions® could help.

Take action to ensure you receive COPAXONE® as prescribed, rather than a generic option:

  • Talk to your doctor.

  • Inform the pharmacy.

  • Check the packaging.

Talk to your doctor about your COPAXONE® prescription

  • Download this guide to prepare for the conversation, whether you are new to COPAXONE® or currently taking COPAXONE® to manage your relapsing MS.

  • Ask your doctor to include specific language such as “Dispense As Written (DAW),” “Brand Medically Necessary” or other wording as indicated by your state regulations on all new and refill COPAXONE® prescriptions to ensure you receive your RMS therapy as prescribed.

  • This action helps ensure the pharmacy cannot substitute your COPAXONE® without your doctor’s permission and notice to you.

Inform the pharmacy you wish to receive COPAXONE®:

  • When filling your COPAXONE® prescription for the first time, talk with your pharmacist to request Teva’s COPAXONE® by name and ensure this information is recorded for all future prescriptions and refills.

  • When you receive your prescription, check the package before leaving the pharmacy (or when receiving your prescription by mail) to make sure it is Teva's COPAXONE®.

  • If you did not receive your medication as prescribed, talk to your pharmacist immediately and request Teva's COPAXONE® for all new prescriptions and refills moving forward. Then call your doctor's office to alert your doctor of the substitution.

COPAXONE® (glatiramer acetate injection) 40 mg and 20 mg packaging

Check the packaging to make sure it's COPAXONE®2:

  • Look for the COPAXONE® name on all labeling and the NDC number on the box.

  • Teva's 3-times-a-week COPAXONE® 40 mg can be identified by the blue plunger.

COPAXONE® (glatiramer acetate injection) 40 mg  blue plunger COPAXONE® (glatiramer acetate injection) 40 mg  blue plunger

How is COPAXONE® made?

Glatiramer acetate injection is a complicated product to manufacture. FDA-approved for over 20 years, Teva uses a controlled process to ensure consistent quality of the product when manufacturing COPAXONE®.2-4

What if I’m switched from COPAXONE® to a generic option by my insurance?

Teva's Shared Solutions® is available at 1-800-887-8100 to answer questions about MS for people who move to a generic glatiramer acetate injection. Note: only people taking Teva's COPAXONE® will continue to receive the full breadth of personalized services that Teva's Shared Solutions® offers.

Use

COPAXONE® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Serious side effects may happen right after or within minutes after you inject COPAXONE® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.

You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE®. Call your doctor right away if you have chest pain while using COPAXONE®.

Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE® and choosing a different injection area each time you use COPAXONE®.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information in the full Prescribing Information.

References:

  1. IQVIA Health National Prescription Audit, September 2018. Data proprietary to IQVIA.

  2. COPAXONE® (glatiramer acetate injection) Current Prescribing Information. Teva Neuroscience, Inc.

  3. Johnson KP. Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update. Expert Opin Drug Metab Toxicol. 2010;6(5):643-660.

  4. Schellekens H, Klinger E, Mühlebach S, Brin J-F, Storm G, Crommelin DJA. The therapeutic equivalence of complex drugs. Regul Toxicol Pharmacol. 2011;59(1):176-183.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave COPAXONE.com and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?